> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Cancels Dynavax Vaccine Committee Meeting
- URL: https://www.fdaweb.com/fda-cancels-dynavax-vaccine-committee-meeting/
- Published: 2016-09-14T12:00:00.000Z
- Updated: 2026-09-14T21:31:56.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136802

*Federal Register* Notice: FDA has canceled an 11/16-planned meeting of the Vaccines and Related Biological Products Advisory Committee that was scheduled to review a hepatitis B vaccine manufactured by Dynavax. FDA says the cancelation will allow time for the agency to review and resolve several outstanding issues. A future advisory committee meeting will be rescheduled as needed. To view this notice, click [*here*](https://www.gpo.gov/fdsys/pkg/FR-2016-09-14/pdf/2016-22051.pdf?ref=fdaweb.com).